Bone Biologics Corp — Director's Dealing 2023

Mar 8, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bone Biologics Corp (BBLG)
CIK: 0001419554
Period of Report: 2022-08-23

Reporting Person: Stroever Bruce (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-08-23	Non-Employee Stock Option	$1.61	A	36845	Acquired	2027-08-23	Common Stock (36845)	Direct

Footnotes

F1: Quarterly through the date of the next annual meeting of the stockholders of the Company following the Grant.